Ginkgo Bioworks Holdings, Inc.
DNA
$9.34
-$0.56-5.66%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -339.55M | -315.19M | -472.08M | -547.03M | -651.19M |
| Total Depreciation and Amortization | 46.98M | 50.68M | 52.22M | 49.72M | 46.91M |
| Total Amortization of Deferred Charges | 14.00M | 13.30M | 13.30M | 13.30M | 13.30M |
| Total Other Non-Cash Items | 131.07M | 143.64M | 226.26M | 254.09M | 305.80M |
| Change in Net Operating Assets | -18.32M | -130.14M | -101.55M | -89.67M | -49.79M |
| Cash from Operations | -165.82M | -237.71M | -281.85M | -319.59M | -334.98M |
| Capital Expenditure | -21.37M | -36.46M | -63.45M | -62.54M | -52.28M |
| Sale of Property, Plant, and Equipment | 57.00K | 648.00K | 648.00K | 648.00K | 2.02M |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -5.40M | -5.40M |
| Divestitures | -- | -- | -- | -- | -42.98M |
| Other Investing Activities | -327.16M | -250.05M | -186.01M | 5.06M | 2.81M |
| Cash from Investing | -348.47M | -285.86M | -248.81M | -62.24M | -95.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -532.00K | -708.00K | -810.00K | -897.00K | -1.01M |
| Issuance of Common Stock | 10.32M | 0.00 | 14.00K | 84.00K | 98.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -23.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -355.00K | -265.00K | -305.00K | -926.00K | -1.23M |
| Cash from Financing | 9.43M | -973.00K | -1.10M | -1.74M | -2.17M |
| Foreign Exchange rate Adjustments | 280.00K | 152.00K | -50.00K | -281.00K | -106.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -504.58M | -524.39M | -531.81M | -383.84M | -433.08M |